Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Gen Digital COO, CLO and Secretary Bryan Ko disposes of USD 866,526 common shares

Gen Digital COO, CLO and Secretary Bryan Ko disposes of USD 866,526 common shares

ReutersReuters2026/09/09 23:17
  • Gen Digital officer Bryan Seuk Ko, COO, CLO, secretary, sold 28,248 common shares on Sept. 4, 2026.
  • Sale priced at USD 30.67 per share, implying proceeds of about USD 866,000.
  • Direct holdings fell to 744,262 shares following the transaction.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gen Digital Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000849399-26-000050), on September 09, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "copper rush" cools off? LME sees the largest delivery in nearly four weeks, copper price retreats to $14,000

Copper prices have stabilized around $14,000 per ton after previously falling, as exchange-tracked warehouses have experienced a new round of inventory deliveries, indicating that the supply shortage has somewhat eased.

智通财经2026/09/15 04:01
The "copper rush" cools off? LME sees the largest delivery in nearly four weeks, copper price retreats to $14,000

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage